• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5081245)   Today's Articles (85)
For: Rowe TC, Tewey KM, Liu LF. Identification of the breakage-reunion subunit of T4 DNA topoisomerase. J Biol Chem 1984. [DOI: 10.1016/s0021-9258(17)47281-4] [Citation(s) in RCA: 60] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]  Open
Number Cited by Other Article(s)
1
Chen X, He Y, Fan T, Wei Y. Efficacy and Safety of Low-Dose Oral Etoposide Combined With Capecitabine for Patients With Postoperative Metastatic Breast Cancer Resistant to Anthracycline/Taxanes. Thorac Cancer 2025;16:e70003. [PMID: 39901856 PMCID: PMC11791407 DOI: 10.1111/1759-7714.70003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2024] [Revised: 01/11/2025] [Accepted: 01/13/2025] [Indexed: 02/05/2025]  Open
2
Wojtaszek JL, Williams RS. From the TOP: Formation, recognition and resolution of topoisomerase DNA protein crosslinks. DNA Repair (Amst) 2024;142:103751. [PMID: 39180935 PMCID: PMC11404304 DOI: 10.1016/j.dnarep.2024.103751] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2024] [Revised: 08/07/2024] [Accepted: 08/12/2024] [Indexed: 08/27/2024]
3
Aparicio T, Baer R, Gottesman M, Gautier J. MRN, CtIP, and BRCA1 mediate repair of topoisomerase II-DNA adducts. J Cell Biol 2016;212:399-408. [PMID: 26880199 PMCID: PMC4754713 DOI: 10.1083/jcb.201504005] [Citation(s) in RCA: 104] [Impact Index Per Article: 11.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2015] [Accepted: 01/19/2016] [Indexed: 02/07/2023]  Open
4
Huang NL, Lin JH. Recovery of the poisoned topoisomerase II for DNA religation: coordinated motion of the cleavage core revealed with the microsecond atomistic simulation. Nucleic Acids Res 2015;43:6772-86. [PMID: 26150421 PMCID: PMC4538842 DOI: 10.1093/nar/gkv672] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2015] [Accepted: 06/19/2015] [Indexed: 01/24/2023]  Open
5
Andres SN, Schellenberg MJ, Wallace BD, Tumbale P, Williams RS. Recognition and repair of chemically heterogeneous structures at DNA ends. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS 2015;56:1-21. [PMID: 25111769 PMCID: PMC4303525 DOI: 10.1002/em.21892] [Citation(s) in RCA: 72] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/09/2014] [Accepted: 07/28/2014] [Indexed: 05/13/2023]
6
Roca J. The path of the DNA along the dimer interface of topoisomerase II. J Biol Chem 2004;279:25783-8. [PMID: 15047688 DOI: 10.1074/jbc.m402555200] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]  Open
7
Miller ES, Kutter E, Mosig G, Arisaka F, Kunisawa T, Rüger W. Bacteriophage T4 genome. Microbiol Mol Biol Rev 2003;67:86-156, table of contents. [PMID: 12626685 PMCID: PMC150520 DOI: 10.1128/mmbr.67.1.86-156.2003] [Citation(s) in RCA: 588] [Impact Index Per Article: 26.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
8
Trigueros S, Roca J. A GyrB-GyrA fusion protein expressed in yeast cells is able to remove DNA supercoils but cannot substitute eukaryotic topoisomerase II. Genes Cells 2002;7:249-57. [PMID: 11918669 DOI: 10.1046/j.1365-2443.2002.00516.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
9
Roca J. Varying levels of positive and negative supercoiling differently affect the efficiency with which topoisomerase II catenates and decatenates DNA. J Mol Biol 2001;305:441-50. [PMID: 11152602 DOI: 10.1006/jmbi.2000.4307] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
10
Das N, Thakur AR. Identification of a Type I Topoisomerase Activity from a Mesophilic Archaeon Methanosarcina barkeri. Anaerobe 2000. [DOI: 10.1006/anae.2000.0347] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
11
Leyh TS. On the advantages of imperfect energetic linkage. Methods Enzymol 1999;308:48-70. [PMID: 10507000 DOI: 10.1016/s0076-6879(99)08005-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
12
Buhler C, Gadelle D, Forterre P, Wang JC, Bergerat A. Reconstitution of DNA topoisomerase VI of the thermophilic archaeon Sulfolobus shibatae from subunits separately overexpressed in Escherichia coli. Nucleic Acids Res 1998;26:5157-62. [PMID: 9801313 PMCID: PMC147979 DOI: 10.1093/nar/26.22.5157] [Citation(s) in RCA: 53] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
13
Kreuzer KN. Bacteriophage T4, a model system for understanding the mechanism of type II topoisomerase inhibitors. BIOCHIMICA ET BIOPHYSICA ACTA 1998;1400:339-47. [PMID: 9748648 DOI: 10.1016/s0167-4781(98)00145-6] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
14
Liu Q, Wang JC. Identification of active site residues in the "GyrA" half of yeast DNA topoisomerase II. J Biol Chem 1998;273:20252-60. [PMID: 9685374 DOI: 10.1074/jbc.273.32.20252] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]  Open
15
Madalengoitia JS, Tepe JJ, Werbovetz KA, Lehnert EK, Macdonald TL. Structure-activity relationship for DNA topoisomerase II-induced DNA cleavage by azatoxin analogues. Bioorg Med Chem 1997;5:1807-15. [PMID: 9354236 DOI: 10.1016/s0968-0896(97)00113-2] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
16
Neece SH, Carles-Kinch K, Tomso DJ, Kreuzer KN. Role of recombinational repair in sensitivity to an antitumour agent that inhibits bacteriophage T4 type II DNA topoisomerase. Mol Microbiol 1996;20:1145-54. [PMID: 8809767 DOI: 10.1111/j.1365-2958.1996.tb02635.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
17
Yasumizu T, Kato J. Clinical trial of daily low-dose oral etoposide for patients with residual or recurrent cancer of the ovary or uterus. JOURNAL OF OBSTETRICS AND GYNAECOLOGY (TOKYO, JAPAN) 1995;21:569-76. [PMID: 8640467 DOI: 10.1111/j.1447-0756.1995.tb00914.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
18
DNA topoisomerase II inhibition by substituted 1,2,3,4-tetrahydro-β-carboline derivatives. Bioorg Med Chem Lett 1994. [DOI: 10.1016/s0960-894x(01)80400-5] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
19
Miller KE, Grace JM, Macdonald TL. The stabilization of DNA topoisomerase II cleavable complex by mitonafide analogs. Bioorg Med Chem Lett 1994. [DOI: 10.1016/s0960-894x(01)80582-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
20
Roca J, Wang JC. DNA transport by a type II DNA topoisomerase: evidence in favor of a two-gate mechanism. Cell 1994;77:609-16. [PMID: 8187179 DOI: 10.1016/0092-8674(94)90222-4] [Citation(s) in RCA: 220] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
21
Ripley LS. Deletion and duplication sequences induced in CHO cells by teniposide (VM-26), a topoisomerase II targeting drug, can be explained by the processing of DNA nicks produced by the drug-topoisomerase interaction. Mutat Res 1994;312:67-78. [PMID: 7510833 DOI: 10.1016/0165-1161(94)90011-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
22
Froelich-Ammon S, Gale K, Osheroff N. Site-specific cleavage of a DNA hairpin by topoisomerase II. DNA secondary structure as a determinant of enzyme recognition/cleavage. J Biol Chem 1994. [DOI: 10.1016/s0021-9258(17)37346-5] [Citation(s) in RCA: 61] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]  Open
23
Purification and characterization of a eukaryotic type 1 topoisomerase from pea chloroplast. J Biol Chem 1994. [DOI: 10.1016/s0021-9258(17)41930-2] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]  Open
24
Ulycznyj PI, Forghani F, DuBow MS. Characterization of functionally important sites in the bacteriophage Mu transposase protein. MOLECULAR & GENERAL GENETICS : MGG 1994;242:272-9. [PMID: 8107674 DOI: 10.1007/bf00280416] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
25
Kreuzer KN. A bacteriophage model system for studying topoisomerase inhibitors. ADVANCES IN PHARMACOLOGY (SAN DIEGO, CALIF.) 1994;29B:171-86. [PMID: 8996607 DOI: 10.1016/s1054-3589(08)61137-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
26
Drlica K, Kreiswirth B. 4-quinolones and the physiology of DNA gyrase. ADVANCES IN PHARMACOLOGY (SAN DIEGO, CALIF.) 1994;29A:263-83. [PMID: 7826862 DOI: 10.1016/s1054-3589(08)60549-9] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
27
Osheroff N, Corbett AH, Elsea SH, Westergaard M. Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classes. Cancer Chemother Pharmacol 1994;34 Suppl:S19-25. [PMID: 8070023 DOI: 10.1007/bf00684859] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
28
Hochhauser D, Harris AL. The role of topoisomerase II alpha and beta in drug resistance. Cancer Treat Rev 1993;19:181-94. [PMID: 8386983 DOI: 10.1016/0305-7372(93)90034-o] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
29
DeMarini DM, Lawrence BK. Prophage induction by DNA topoisomerase II poisons and reactive-oxygen species: role of DNA breaks. Mutat Res 1992;267:1-17. [PMID: 1373845 DOI: 10.1016/0027-5107(92)90106-c] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
30
Murphy PB, Hainsworth JD, Greco FA, Hande KR, DeVore RF, Johnson DH. A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancer. Cancer 1992;69:370-5. [PMID: 1309432 DOI: 10.1002/1097-0142(19920115)69:2<370::aid-cncr2820690217>3.0.co;2-e] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
31
Johnson DH, Hainsworth JD, Hande KR, Greco FA. Current status of etoposide in the management of small cell lung cancer. Cancer 1991;67:231-44. [PMID: 1845846 DOI: 10.1002/1097-0142(19910101)67:1+<231::aid-cncr2820671305>3.0.co;2-e] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
32
Reece RJ, Maxwell A. DNA gyrase: structure and function. Crit Rev Biochem Mol Biol 1991;26:335-75. [PMID: 1657531 DOI: 10.3109/10409239109114072] [Citation(s) in RCA: 499] [Impact Index Per Article: 14.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
33
Huff AC, Kreuzer KN. Evidence for a common mechanism of action for antitumor and antibacterial agents that inhibit type II DNA topoisomerases. J Biol Chem 1990. [DOI: 10.1016/s0021-9258(17)30531-8] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]  Open
34
Thomas CD, Balson DF, Shaw WV. In vitro studies of the initiation of staphylococcal plasmid replication. Specificity of RepD for its origin (oriD) and characterization of the Rep-ori tyrosyl ester intermediate. J Biol Chem 1990. [DOI: 10.1016/s0021-9258(19)39392-5] [Citation(s) in RCA: 61] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]  Open
35
Huff AC, Ward RE, Kreuzer KN. Mutational alteration of the breakage/resealing subunit of bacteriophage T4 DNA topoisomerase confers resistance to antitumor agent m-AMSA. MOLECULAR & GENERAL GENETICS : MGG 1990;221:27-32. [PMID: 2157956 DOI: 10.1007/bf00280363] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
36
Gupta R. Tests for the genotoxicity of m-AMSA, etoposide, teniposide and ellipticine in Neurospora crassa. Mutat Res 1990;240:47-58. [PMID: 2137196 DOI: 10.1016/0165-1218(90)90007-o] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
37
Yamada S, Ando K, Koike S, Isono K. Etoposide protects mice from radiation-induced bone marrow death. Jpn J Cancer Res 1990;81:112-4. [PMID: 2110126 PMCID: PMC5963894 DOI: 10.1111/j.1349-7006.1990.tb02535.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]  Open
38
Hainsworth JD, Johnson DH, Frazier SR, Greco FA. Chronic daily administration of oral etoposide in refractory lymphoma. Eur J Cancer 1990;26:818-21. [PMID: 2145902 DOI: 10.1016/0277-5379(90)90160-u] [Citation(s) in RCA: 44] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
39
Tobin GJ, Young DC, Flanegan JB. Self-catalyzed linkage of poliovirus terminal protein VPg to poliovirus RNA. Cell 1989;59:511-9. [PMID: 2553272 DOI: 10.1016/0092-8674(89)90034-2] [Citation(s) in RCA: 63] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
40
Wyckoff E, Natalie D, Nolan JM, Lee M, Hsieh T. Structure of the Drosophila DNA topoisomerase II gene. Nucleotide sequence and homology among topoisomerases II. J Mol Biol 1989;205:1-13. [PMID: 2538621 DOI: 10.1016/0022-2836(89)90361-6] [Citation(s) in RCA: 135] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
41
Osheroff N. Biochemical basis for the interactions of type I and type II topoisomerases with DNA. Pharmacol Ther 1989;41:223-41. [PMID: 2540496 DOI: 10.1016/0163-7258(89)90108-3] [Citation(s) in RCA: 210] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
42
Kreuzer KN. DNA topoisomerases as potential targets of antiviral action. Pharmacol Ther 1989;43:377-95. [PMID: 2554345 DOI: 10.1016/0163-7258(89)90017-x] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
43
Drlica K, Coughlin S. Inhibitors of DNA gyrase. Pharmacol Ther 1989;44:107-21. [PMID: 2562411 DOI: 10.1016/0163-7258(89)90093-4] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
44
Danks MK, Schmidt CA, Cirtain MC, Suttle DP, Beck WT. Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26. Biochemistry 1988;27:8861-9. [PMID: 2853972 DOI: 10.1021/bi00424a026] [Citation(s) in RCA: 171] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
45
Pargellis CA, Nunes-Düby SE, de Vargas LM, Landy A. Suicide recombination substrates yield covalent lambda integrase-DNA complexes and lead to identification of the active site tyrosine. J Biol Chem 1988. [DOI: 10.1016/s0021-9258(18)68552-7] [Citation(s) in RCA: 79] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]  Open
46
Ripley LS, Dubins JS, deBoer JG, DeMarini DM, Bogerd AM, Kreuzer KN. Hotspot sites for acridine-induced frameshift mutations in bacteriophage T4 correspond to sites of action of the T4 type II topoisomerase. J Mol Biol 1988;200:665-80. [PMID: 2842508 DOI: 10.1016/0022-2836(88)90479-2] [Citation(s) in RCA: 59] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
47
Cheng CC. Structural aspects of antineoplastic agents--a new approach. PROGRESS IN MEDICINAL CHEMISTRY 1988;25:35-83. [PMID: 3076970 DOI: 10.1016/s0079-6468(08)70277-7] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
48
DeMarini DM, Lawrence BK. Mutagenicity of topoisomerase-active agents in bacteriophage T4. TERATOGENESIS, CARCINOGENESIS, AND MUTAGENESIS 1988;8:293-301. [PMID: 2905838 DOI: 10.1002/tcm.1770080506] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
49
Drake FH, Zimmerman JP, McCabe FL, Bartus HF, Per SR, Sullivan DM, Ross WE, Mattern MR, Johnson RK, Crooke ST. Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme. J Biol Chem 1987. [DOI: 10.1016/s0021-9258(18)49317-9] [Citation(s) in RCA: 190] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]  Open
50
Zachary A, Black LW. Topoisomerase II and other DNA-delay and DNA-arrest mutations impair bacteriophage T4 DNA packaging in vivo and in vitro. J Virol 1986;60:97-104. [PMID: 3018302 PMCID: PMC253906 DOI: 10.1128/jvi.60.1.97-104.1986] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]  Open
PrevPage 1 of 2 12Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA